In screening a library of natural and synthetic products for eukaryotic translation modulators, we identified two natural products, isohymenialdisine and hymenialdisine, that exhibit stimulatory effects on translation. The characterization of these compounds led to the insight that mRNA used to program the translation extracts during high-throughput assay setup was leading to phosphorylation of eIF2a, a potent negative regulatory event that is mediated by one of four kinases. We identified double-stranded RNA-dependent protein kinase (PKR) as the eIF2a kinase that was being activated by exogenously added mRNA template. Characterization of the mode of action of isohymenialdisine revealed that it directly acts on PKR by inhibiting autophosphorylation, perturbs the PKR-eIF2a phosphorylation axis, and can be modeled into the PKR ATP binding site. Our results identify a source of ''false positives'' for high-throughput screen campaigns using translation extracts, raising a cautionary note for this type of screen.
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High-throughput screens (HTSs) 1 have been the mainstay of drug discovery programs, chemical biology efforts, and RNA interference (RNA i )-based genetic screens. The design and construction of such screens stems from a fundamental understanding of protein function or activity, the desire to obtain a unique tool that can dissect a complex biological process, or the need to identify vulnerabilities for a specific therapeutic purpose. Decisions taken during the HTS design process have far-reaching consequences for the nature of molecules that will be identified as well as the spectrum of targets that will be probed-with the results affecting the subsequent value of the identified molecules as useful reagents or drugs. For example, the dependence on delivery of extraneous factors to an HTS assay may lead to the identification of ''false positives'' due to confounding effects on availability or activity of that component. Such events increase the downstream workload and necessitate the implementation of counterscreens and secondary/tertiary confirmatory assays. Protein synthesis has been probed extensively using translation-competent extracts in several HTS assays, with interests stemming from the desire to identify novel antimicrobial drugs [1, 2] , block expression of specific mRNA transcripts [3, 4] , identify compounds that target initiation and show antineoplastic activity [5] [6] [7] [8] , and correct read-through nonsense mutations as a means of overcoming nonsense-based genetic defects [9] . In screens designed to identify inhibitors of mammalian translation, extracts from reticulocytes, HeLa cells, and Krebs-2 ascites carcinoma have been used extensively [2, 5, 9] . Each system has its peculiarities, with reticulocyte lysates being the more efficient extract and HeLa and Krebs 2 cell lysates being more cap dependent and faithfully recapitulating the cap-poly(A) synergy [10, 11] .
The process of translation is suppressed by a number of regulatory kinases that (i) control the phosphorylation status of eukaryotic elongation factor (eEF) 2 to couple translation inhibition (eEF2 phosphorylation) with cellular processes such as mitosis [12] ; (ii) regulate ribosome recruitment to mRNA templates by modulating subunit availability of eukaryotic initiation factor (eIF) 4F [13, 14] , an activity responsible for preparing a ribosome landing pad in the vicinity of the 5 0 cap structure; (iii) and regulate the phosphorylation status of eIF2a [15] . During initiation, eIF2 forms a ternary complex with GTP and initiator methionyl-tRNA (Met-tRNA i Met ), which then binds to 40S ribosomal subunits to form 43S preinitiation complexes (PICs) along with other eIFs. Following recruitment of the PICs to mRNA templates, the 43S complex scans the 5 0 -untranslated regions (UTRs) of mRNA templates where, on recognition of the appropriate AUG start codon, eIF2ÁGTP is converted to an inactive GDP-bound state. The guanine nucleotide exchange factor eIF2B is then required to recycle eIF2ÁGDP to eIF2ÁGTP for a new round of initiation, a process that is inhibited if eIF2a is phosphorylated [16] [17] [18] . eIF2 is a trimeric complex consisting of a, b, and c subunits, and phosphorylation of the a subunit at Ser51 increases the affinity of eIF2ÁGDP for eIF2B, leading to sequestration of eIF2ÁGDP-eIF2B complexes. Because eIF2 is present in excess of eIF2B, small changes in the phosphorylation status of eIF2 lead to a significant inhibitory effect on global protein synthesis [19, 20] .
In mammals, four eIF2a kinases have been identified and characterized extensively: general control nondepressible 2 (GCN2), PKR-like endoplasmic reticulum kinase (PERK), heme-regulated inhibitor (HRI), and double-stranded RNA-dependent protein kinase (PKR). They share a conserved kinase domain (KD) but have distinct regulatory domains that respond to different stress signals; GCN2 senses amino acid deprivation and ultraviolet (UV) irradiation [21, 22] , PERK is active in response to accumulation of misfolded proteins in the endoplasmic reticulum [23] , HRI responds to heme deficiency, oxidative stress, and heat shock in erythroid tissues [24] , and PKR is activated by double-stranded RNA (dsRNA) [25, 26] . PKR is a serine/threonine kinase that phosphorylates eIF2a on binding to dsRNA of viral, synthetic, or cellular origin. Binding to dsRNA promotes dimerization of PKR and enables autophosphorylation and activation, which in turn inhibits translation via eIF2a phosphorylation.
During the course of a recent screening campaign, we identified two compounds, isohymenialdisine and hymenialdisine, that had the unusual property of stimulating translation. In characterizing the effect of these compounds, we found that they blocked PKR activation-an event that was unexpectedly caused by the mRNA preparations used to program the in vitro translation extracts. Our experiments identify a potential common source of false positives in HTSs designed to probe the mammalian process and extend the inhibitory spectrum of isohymenialdisine and hymenialdisine.
Materials and methods

Materials and general methods
Restriction endonucleases, SP6, and T7 RNA polymerase were purchased from New England Biolabs, and T3 RNA polymerase was purchased from Fermentas. and [c-32 P]ATP (6000 Ci/mmol) were purchased from PerkinElmer.
Cycloheximide (CHX, Bishop) was resuspended in H 2 O, whereas homoharringtonine (HHT, Sigma-Aldrich), C16 (PKRi, Calbiochem) [27] , SyK inhibitor (GCN2i, Calbiochem) [28] , GSK PERKi (Toronto Research Chemicals) [29, 30] , and quercetin (HRIi, Sigma-Aldrich) [31, 32] were resuspended in 100% dimethyl sulfoxide (DMSO). Antibodies were as follows: anti-phospho-eIF2a (cat. no. 3597), anti-eIF2a (cat. no. 9722), and anti-eEF2 (cat. no. 2332) were obtained from Cell Signaling Technology. Preparation of plasmid DNA, restriction digestion, agarose gel electrophoresis of DNA, and bacterial transformations were carried out using standard methods [33] .
Isolation of hymenialdisine and its derivatives from Stylissa massa
The Stylissa massa sponge sample was collected under contract with Pfizer Research Laboratories (St. Louis, MO, USA). When Pfizer disbanded its natural products program, it generously donated its marine invertebrate collection to one of the current authors (R.J.A.). Specimens were collected by hand using SCUBA on a coral reef slope at 50 feet off Manado, Indonesia, in November 1994 (N 01°31 0 3 00 , E 124°50 0 07 00 ). A voucher sample has been deposited at the Netherlands Centre for Biodiversity Naturalis (Leiden, The Netherlands).
Freshly collected sponge was frozen on-site and transported frozen. Lyophilized sponge (5 g) was cut into small pieces and immersed in and subsequently extracted repeatedly with MeOH (3 Â 50 ml) at room temperature. The combined methanolic extracts were concentrated in vacuo, and the resultant extract was then partitioned between EtOAc (3 Â 5 ml) and H 2 O (15 ml). The resulting aqueous extract was then extracted with n-BuOH (3 Â 5 ml). The combined n-BuOH extracts were evaporated to dryness, and the resulting oil was chromatographed on Sephadex LH-20 with MeOH as eluent. The late eluting active fraction was purified via C 18 reversed-phase high-performance liquid chromatography (HPLC) using a CSC-Inertsil 150A/ODS2 column (5 lm, 25 Â 0.94 cm) with 9:1 (0.05% trifluoroacetic acid [TFA]/H 2 O)/ MeCN as eluent to give pure samples of hymenialdisine (1, 6.6 mg), debromohymenialdisine (2, 2.4 mg), and isohymenialdisine (3, 3.8 mg). The structures of 1, 2, and 3 were established by standard one-and two-dimensional NMR spectroscopic and HRE SIMS analyses.
In vitro transcription and translation reactions
In vitro transcriptions were performed as described previously [5, 34] . Plasmids pKS/FF/EMC/Ren, pSP/(CAG) 33 HANCE, dried, and exposed to Blue Ray film (VWR). In vitro translations were performed in Krebs extracts as described previously [5] and in Escherichia coli S30 extracts as directed by the manufacturer (Promega).
In vitro kinase assays
Plasmids pGEX-5X-1-KD and pET-15b/eIF2a were transformed into E. coli BL21(DE3)/pLysS. GST-PKR-KD and His 6 -eIF2a were expressed and purified as described previously [27, 35] . The eIF2a kinase assay and PKR autophosphorylation assay were performed as reported with slight modifications [27, 35] . For eIF2a kinase assays, 0.5 lg of GST-PKR-KD and His 6 -eIF2a was incubated with 50 lM ATP in kinase buffer (20 mM Tris-HCl [pH 7.6], 10 mM KCl, 10 mM MgCl 2 , and 10% glycerol) at 30°C for 30 min. Phosphorylation of eIF2a was assessed by Western blotting. For PKR autophosphorylation assays, 0.5 lg of GST-PKR-KD was incubated with 50 lM ATP in kinase buffer at 30°C for 30 min. The reaction was quenched with 3 Â SDS-PAGE (polyacrylamide gel electrophoresis) loading buffer, boiled, and resolved in 10% SDSpolyacrylamide gels. The gel was dried and exposed to Blue Ray film (VWR).
Computational mapping of the PKR structure
Mapping was performed on the PKR KD-eIF2a-AMP-PNP complex (PDB ID 2A19). Chain A representing eIF2a, the ligand AMP-PNP, and all crystallographic water molecules were removed prior to calculations. One PKR monomer (chain B) was globally mapped using the FTMap server (http://ftmap.bu.edu). FTMap places molecular probes, small organic molecules containing various functional groups, on a dense grid defined around the entire protein without any restriction, finds favorable positions using empirical energy functions, further refines the selected poses by energy minimization, clusters the low-energy conformations, calculates the partition function for each cluster, and ranks the clusters on the basis of their probabilities [36] . The consensus sites are then defined as those where clusters of different probes overlap; such consensus sites identify the binding hot spots, that is, regions of interactions that substantially contribute to the binding free energy and, hence, are of prime importance to ligand binding and drug design.
Docking of hymenialdisine and isohymenialdisine
Based on the mapping results, a box with 4 Å padding was created around the putative binding site. The docking was carried out using the standard settings of AutoDock Vina 1.1.2 [37] , and a number of the lowest energy binding modes were retained for each ligand. The selection of the most likely pose was based on the atom densities calculated from the mapping results [38] . We considered each retained pose separately, for each atom summed the atomic densities on the grid points within a 1-Å radius, and then added these values for all atoms. The poses were ranked on the basis of this overlap measure, and the pose with the best overlap was selected [38] . The selected complexes were minimized using the Charmm potential allowing for complete flexibility [39] .
Results
Identification of hymenialdisine and isohymenialdisine as stimulators of translation in vitro
During the course of screening natural and synthetic products for inhibitors of protein synthesis using in vitro translation assays, we noticed a stimulatory activity during bioassay-guided fractionation of one extract from S. massa. Hymenialdisine (1), debromohymenialdisine (2), and isohymenialdisine (3) were purified and individually characterized in RRL programmed with FF/EMC/Ren (Fig. 1A and B) . The FF luciferase protein is synthesized in a 5 0 -cap-dependent manner, whereas production of Ren luciferase is mediated by the ability of the encephalomyocarditis (EMC) internal ribosome entry site (IRES) to directly recruit ribosomes [40] . Anisomycin and hippuristanol, inhibitors of elongation and initiation, respectively [41] , blocked production of both FF and Ren luciferase, as expected ( Fig. 1C and D) . Titration of hymenialdisine and isohymenialdisine stimulated production of both FF and Ren, with a more pronounced effect observed on EMC-driven Ren production ( Fig. 1C and D) . Debromohymenialdisine had no effect on the translational output of FF/EMC/Ren ( Fig. 1C ; cf. lanes 7-9 with lane 1). Neither hymenialdisine nor isohymenialdisine stimulated luciferase enzyme activity per se when incubated in the presence of FF or Ren proteins, indicating that the results are not due to specific stimulation of luciferase enzyme activity (U. Shin; data not shown).
To determine whether hymenialdisine and isohymenialdisine could also stimulate translation directed from other IRESes, we titrated compounds 1 to 3 in RRL that had been programmed with FF/HCV/Ren or Ren/CrPV/FF (Fig. 2A) . The hepatitis C virus (HCV) IRES does not require eIF4E, eIF4G, or eIF4A for ribosome recruitment, whereas the cricket paralysis virus (CrPV) IRES is capable of recruiting ribosomes in the absence of any canonical initiation factors [40, 42, 43] . In the case of FF/HCV/Ren, hymenialdisine and isohymenialdisine stimulated both cap-dependent (FF) and IRESmediated (Ren) translation (Fig. 2B) . In contrast, the CrPV IRES was refractory to stimulation by any of the compounds used in this study, whereas cap-dependent translation was stimulated by hymenialdisine and isohymenialdisine (Fig. 2C) .
To assess whether these effects would also be observed in other mammalian translation systems, we tested extracts prepared from Krebs-2 cells programmed with FF/EMC/Ren (Fig. 3A) . We observed a stimulatory effect on production of FF and Ren in the presence of isohymenialdisine, but not at similar concentrations of hymenialdisine or debromohymenialdisine. None of the compounds af- fected translation in E. coli-coupled transcription-translation extracts when added to a final concentration of 50 lM (Fig. 3B) . Taken together, these results indicate that the effects of isohymenialdisine on increasing the yield of FF and Ren from FF/ EMC/Ren are not unique to RRL and extend to Krebs extracts but not to bacterial translation systems.
To obtain insight into the kinetics of stimulation exerted by compounds 1 to 3, we documented the kinetics of stimulation on the addition of compounds to actively translating extracts (Fig. 4) . Here, RRLs were programmed with FF Luc mRNA (Fig. 4A) , compounds were added 15 min after the start of the translation reactions, and aliquots were removed during the course of translation to monitor the effects on protein production. In this situation, the addition of CHX results in a rapid cessation of translation elongation, with little protein production occurring over the ensuing 75 min (Fig. 4B) . HHT allows ribosomes to run off because it has low affinity for translating polysomes but inhibits the first step of elongation [44] . When added to translating RRLs, protein synthesis continues unabated for approximately 5 to 7 min while ribosomes run off preloaded mRNA template and then translation stops (Fig. 4C) . The addition of vehicle (DMSO) was accompanied by an increase in FF Luc production from 15 to 45 min, followed by a plateauing and little change in FF Luc output beyond 60 min. Similar results were obtained when debromohymenialdisine (2) was added to translating RRLs (Fig. 4B) . In contrast, the addition of isohymenialdisine (3) caused a significant increase ($2.5-fold) in FF Luc output that was linear for a much longer period of time than observed for the vehicle control extracts (Fig. 4B) . The addition of hymenialdisine (1) also stimulated production of FF Luc, but to a lesser degree than obtained with isohymenialdisine (Fig. 4C) .
Isohymenialdisine inhibits PKR-mediated phosphorylation of eIF2a
One mechanism that can limit the translational output of mammalian in vitro translation extracts is phosphorylation of eIF2a (see introductory paragraphs). Indeed, in vitro transcribed RNA using phage polymerases often contains double-stranded product due to a snap-back phenomenon that can lead to activation of PKR in translation extracts [45] . To directly test whether this was occurring in our system, we probed RRL that had been incubated in the absence or presence of in vitro transcribed RNA. The results clearly show that phosphorylation of eIF2a occurs as a function of time upon the addition of in vitro transcribed RNA (Fig. 4D) .
To test whether such an event was limiting the synthesis potential of our translation reactions, we assessed the activity of inhibitors to the four eIF2a kinases in reticulocyte lysates (Fig. 4E and F) . Small molecules targeting PERK (Fig. 4E) [29, 30] , HRI (Fig. 4E ) [31, 32] , and GCN2 (Fig. 4F ) [28] had little influence on FF production when added to RRLs programmed with FF-HCV-Ren mRNA. In contrast, the addition of the PKR inhibitor, C16 [27] , increased FF production to levels that resembled those obtained with isohymenialdisine (Fig. 4F) . These results indicate that inhibition of PKR can increase translational output in RRL and phenocopies the effects of isohymenialdisine. To assess whether the addition of isohymenialdisine (3) to RRL would reduce levels of phosphoeIF2a in RRL, we analyzed aliquots removed 5 and 90 min following the addition of compound to translating RRL extracts (Fig. 4G) . The results indicate that isohymenialdisine (3), like the PKR inhibitor C16, can reduce phospho-eIF2a levels in RRL programmed with exogenous mRNA (Fig. 4G) . The effect of hymenialdisine was not as pronounced as that of isohymenialdisine, and it paralleled the relative potencies of these two compounds for stimulation of translation (Fig. 4C) . Thus, we focused our attention on the characterization of isohymenialdisine.
To test whether isohymenialdisine (3) was capable of inhibiting PKR-mediated phosphorylation of eIF2a, we expressed and purified recombinant His 6 -eIF2a and the GST-PKR-KD. GST-PKR-KD has been previously used to characterize small molecule inhibitors of PKR [27] and is capable of phosphorylating His 6 -eIF2a in vitro ( Fig. 5A; cf. lanes 4 and 5 with lanes 1-3) . PKRi and isohymenialdisine (3) inhibited eIF2a phosphorylation in vitro ( Fig. 5A ; cf. lanes 6-9 with lane 5). To extend these results and demonstrate a direct effect of isohymenialdisine (3) on PKR kinase activity, we incubated GST-PKR-KD with [c-32 P]ATP and scored for cross-phosphorylation of PKR. In this scenario, the heterologous GST dimerization domain functionally substitutes for dsRNA and enables dimerization and activation of the KD [46] . We found that PKRi and isohymenialdisine (3) inhibited autophosphorylation of PKR-KD ( Fig. 5B ; cf. lanes 4-7 with lanes 2 and 3), consistent with isohymenialdisine being able to directly inhibit PKR activation.
Structure modeling predicts binding of hymenialdisine and isohymenialdisine to the PKR ATP pocket
To obtain insight into the interactions between hymenialdisine and isohymenialdisine with PKR, we mapped the KD of PKR for druggable ''hot spots'' [36] and docked the two compounds to PKR based on the mapping results [38] . The PKR structure was derived from the PKR KD-eIF2a-AMP-PNP complex by stripping the eIF2a and AMP-PNP domains [47] . We found that the main hot spot (i.e., the energetically most important region of the binding site, shown as cyan lines) is in a deep crevice within the ATP site (Fig. 5C) . The bound AMP-PNP is superimposed (shown as yellow extracts. Extracts were programmed with pBESTluc DNA (50 ng/ll), and the obtained firefly luciferase activity was normalized to vehicle (0.25% DMSO) controls. The average firefly luciferase value in the vehicle controls was approximately 500,000 RLU (n = 3). Bars denote errors of the means. RLU, relative light units; Aniso, anisomycin; Hipp, hippuristanol.
sticks) for reference and highlights that the main hot spot overlaps with the adenylate ester moiety (see expanded view in Fig. 5C ). A top-down view of the main hot spot revealed three probe cluster sites: (i) a large consensus site CS1 (cyan, 28 probe clusters), (ii) consensus site CS4 (blue, 7 probe clusters), and (iii) consensus site CS8 (green, 3 probe clusters) (Fig. 5D) . Superimposition of AMP-PNP onto the probe cluster sites showed that the ligand overlaps with the central ring in the major hot spot CS1 but does not occupy two hot spot regions that expand from the ring (Fig. 5E ). The best docked pose of hymenialdisine fits better into these additional hot spots (Fig. 5F ) in spite of the fact that we mapped the PKR structure from its complex with AMP-PNP. It was shown previously that better fits into hot spots imply better ligand efficiency and higher affinity [48] . In addition, hymenialdisine forms five hydrogen bonds with PKR. Three hydrogen bonds are on the pyrroloazepine double ring: between the N1 atom of the pyrrole ring and the carbonyl oxygen of C369, between the O1 carbonyl oxygen of the azepine ring and the backbone NH group of C369, and between the N2 amide of the azepine ring and the carbonyl oxygen of E367 (Fig. 5F ). The other two hydrogen bonds are on the guanidine ring system: between the N5 amino group and the carbonyl oxygen of S418 and between the O2 of the guanidine ring and the side chain of K296 (Fig. 5F ). We note that the same atoms of hymenialdisine form hydrogen bonds with cyclin-dependent kinase (CDK) 2, with the only difference being that O2 of the guanidine ring participates in a water-mediated interaction. In contrast, the original ligand in the X-ray structure, AMP-PNP, forms only two hydrogen bonds with PKR (Fig. 5E ). The bromine atom of hymenialdisine is predicted to interact with the amide CO group of the Q376 side chain (Fig. 5F ). Such halogen bonds are known to be favorable [49] , which may explain why debromohymenialdisine is a weaker binder than hymenialdisine. Isohymenialdisine also fits into the binding hot spot very well. Four of the hydrogen bonds are the same as those for hymenialdisine (Fig. 5G) . Rather than directly interacting, the N5 amino group of the guanidine ring and the carbonyl oxygen of S418 appear to form a water-mediated hydrogen bond, which is not modeled in our calculations and, hence, is not shown in Fig. 5G . The bromine atom is moved into a hydrophobic environment and forms an interaction with the side chain of M366, which is expected to be more favorable than its interaction with the amide CO of Q376. These model data offer a potential mechanism by which isohymenialdisine and hymenialdisine inhibit PKR function.
Discussion
Hymenialdisine has been characterized as an inhibitor of CDK1 (IC 50 = 22 nM) and CDK2 (IC 50 = 40 nM), glycogen synthase kinase 3b (IC 50 = 10 nM), and casein kinase 1 (IC 50 = 35 nM) and has been shown to function as a competitive inhibitor of ATP [50] . It is also a potent inhibitor of NF-jB in U937 cells [51] and of mitogenactivated protein kinase kinase-1 (MEK-1) [52] . Previous studies using affinity chromatography approaches [53] and computation approaches [54] identified a number of additional kinase targets, albeit not PKR. We found that hymenialdisine also inhibits eIF2a phosphorylation ( Fig. 4G ; cf. lane 3 with lane 1 of p-eIF2a blot). Although little has been reported in the literature on isohymenialdisine, it appears to be more potent at stimulating translation (Figs. 1, 2 and 4) and inhibiting eIF2a phosphorylation than hymenialdisine ( Fig. 4G ; cf. lane 10 with lane 8). Our modeling data are consistent with the ability of isohymenialdisine (Fig. 5G) and hymenialdisine ( Fig. 5F ) to bind to the ATP binding pocket of PKR.
In vitro translation extracts are powerful systems that have been useful in dissecting and characterizing various steps of protein synthesis and in generating proteins for functional studies. Mammalian extracts prepared from RRLs, HeLa cells, or Krebs-2 cells have been employed extensively to delineate mRNA structural features required for efficient recruitment of 43S PICs to mRNA templates [55] . One major mechanism that limits the translation rates of current mammalian extracts is phosphorylation of eIF2a [56] . Indeed, heme is typically supplemented to RRL to prevent HRI from phosphorylating eIF2a and rapidly inactivating translation initiation [57] . More recently, phosphorylation of eIF2a in cell-free systems has been characterized by Mikami and coworkers [58] , who attributed eIF2a phosphorylation to PERK, PKR, and GCN2 and showed that the induced translation inhibition could be overcome by the addition of GADD34 (which stimulated eIF2a dephosphorylation) or the vaccinia virus K3L eIF2a pseudosubstrate [58] . In addition, extracts prepared from murine embryonic fibroblasts harboring an eIF2a homozygous knock-in mutation (Ser51 to Ala change that no longer is a substrate for the eIF2a kinases) have a translational efficiency that is 30-fold higher than that of extracts made from wild-type cells. These studies document that a current limitation of in vitro mammalian translation extracts occurs when eIF2a phosphorylated.
In the experiments reported here, we suspected that our in vitro transcribed mRNA was responsible for in vitro phosphorylation of eIF2a-an effect that could be blocked by a small molecule inhibitor of PKR (Fig. 4G) . This phenomenon has also been reported by Gunnery and coworkers [45] . Because of this, we were fortunate to detect a translation stimulatory activity in S. massa extracts and could attribute this to isohymenialdisine (and, to a lesser extent, hymenialdisine). Consistent with isohymenialdisine blocking eIF2a phosphorylation is the lack of stimulation by this compound on the CrPV IRES (Fig. 2C) , which bypasses the requirement for eIF2 during the initiation process [42] . PKR can also be activated in an RNA-independent manner by heterodimerizing with PACT (protein activator of the interferon-induced protein kinase R) [59] . Although we cannot formally exclude an effect of isohymenialdisine on this interaction, our in vitro kinase studies with recombinant PKR indicate a direct effect on PKR activity (Fig. 5B) .
There is much interest in targeting the translation process, and consequently robust in vitro functional assays have been developed for HTS screens in search of inhibitors of cap-dependent translation and HCV IRES-mediated translation [5, 60] . Such assays rely on programming extracts with exogenous mRNA, which our results have shown can result in unwanted activation of PKR. This could be prevented by supplementing the lysates with a PKR inhibitor, more rigorous purification of the mRNA template, or use of extracts prepared from eIF2a S51A cells, making the assays more sensitive by improving the signal/background ratio. This would also avoid the time-consuming pursuit of compounds that affect translation by modulating eIF2a phosphorylation.
